{"brief_title": "ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)", "brief_summary": "This study is being carried out to see if ZD4054 (Zibotentan) is effective in treating prostate cancer and spread of cancer to the bone, and if so, how it compares with placebo (sugar pill). The study will also provide further information on the safety of ZD4054 (Zibotentan).", "condition": ["Prostate Cancer"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["ZD4054 15 mg", "Placebo", "ZD4054 10 mg"], "description": ["15 mg oral tablet once daily", "10mg oral tablet once daily"], "arm_group_label": ["ZD4054 15 mg", "Placebo", "ZD4054 10 mg"], "other_name": ["Zibotentan", "(Zibotentan)"], "criteria": "Inclusion Criteria: - Surgically or medically castrated - Bone metastasis - Rising PSA Exclusion Criteria: - Opiate use - Prior chemotherapy", "gender": "Male", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "pain-free or mildly symptomatic", "mesh_term": ["Prostatic Neoplasms", "Neoplasm Metastasis"], "id": "NCT00090363"}